IL-1β can enhance inflammatory responses in the bronchi and alveoli in patients with lung injury, and the levels of inflammatory cytokines such as IL-1 and TNF are elevated in the lungs of patients with COVID-19. The gene discussed is IL1B; the disease is COVID-19.